Prelude Therapeutics PRLD shares fell 17.4% to $0.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $49.5 million. Stoke Therapeutics STOK shares declined by 11 ...
Invivyd, Inc. (NASDAQ:IVVD – Get Free Report) was the recipient of unusually large options trading on Thursday. Traders ...
The market in the United States has shown a flat performance over the last week but has risen by 22% over the past year, with earnings forecasted to grow by 15% annually. In this context, identifying ...
Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Invivyd (IVVD) announced a strategic partnership with professional football coach Jim Harbaugh to raise awareness about the ongoing short and ...
Proud to partner with a company driven to provide options for COVID-19, Coach Harbaugh encourages Americans, especially the immunocompromised, to learn more about the short and potential long-term ...